Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12110272 Deuterated tryptamine derivatives and methods of use

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 17, 2023
0
Date of Patent
October 8, 2024
0
Patent Application Number
18353492
0
Patent Citations
‌
US Patent 9139821 Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
0
‌
US Patent 11242318 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 11312684 Pharmaceutically acceptable salts of psilocin and uses thereof
0
‌
US Patent 11324762 Deuterated derivatives of psilocybin and uses thereof
0
‌
US Patent 11471417 Deuterated N,N-dimethyltryptamine compounds
0
‌
US Patent 11680043 Pharmaceutically acceptable salts of psilocin and uses thereof
0
‌
US Patent 11746088 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 11834410 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 11958807 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 7052846 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
0
•••
Patent Inventor Names
Alex Nivorozhkin
0
Michael Palfreyman
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12110272
0
Patent Primary Examiner
‌
Kamal A Saeed
0
CPC Code
‌
C07B 2200/05
0
‌
A61K 9/20
0
‌
C07D 209/16
0

Find more entities like US Patent 12110272 Deuterated tryptamine derivatives and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.